雅运股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Yayun Co., Ltd. (SH 603790) held its 19th meeting of the fifth board of directors on October 24, 2025, to review the proposal for amending the "Board Meeting Rules" [1] - For the year 2024, the revenue composition of Yayun Co., Ltd. is entirely from the textile chemicals industry, accounting for 100.0% [1] - As of the report date, Yayun Co., Ltd. has a market capitalization of 4.1 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdongfang Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]